Ebola is a household name. Its close relatives are not — but they can be just as deadly. One of them, Bundibugyo virus, has now caused its largest outbreak on record, a sobering reminder that the family of viruses behind hemorrhagic fever extends well beyond the strains that make headlines.

What Bundibugyo virus is

Bundibugyo is a filovirus — the same family as Ebola and Marburg — and one of the several species that can cause Ebola disease. First identified in Uganda in 2007, it had caused only minimal recognized activity for years, fading into the background of global health concerns. That has now changed.

The current outbreak

An outbreak across the Democratic Republic of Congo and Uganda had reached 695 confirmed cases and 138 confirmed deaths as of June 11, 2026 — surpassing the two previous known outbreaks (Uganda in 2007 and DRC in 2012) combined. It was formally recognized only after the death of a nurse, underscoring how easily such outbreaks can smolder before detection.

Why it’s so dangerous

Like other filoviruses, Bundibugyo causes a severe hemorrhagic fever: widespread inflammation, damage to blood vessels, uncontrolled bleeding and multiple organ failure. It spreads through direct contact with infected bodily fluids, putting family members, caregivers and health workers at particular risk. A cruel diagnostic wrinkle: early symptoms overlap with malaria and typhoid — common illnesses in the region — so cases can be missed without laboratory confirmation.

The treatment gap

Here is the crux of the concern: there is no licensed vaccine or therapeutic specifically for Bundibugyo. Some vaccines developed for other filovirus species “could offer at least some protection,” but dedicated tools are lacking — a contrast with the Zaire ebolavirus strain, for which effective vaccines now exist. Compounding the problem, limited laboratory capacity in the DRC delays diagnosis. As Boston University’s Nancy Sullivan, who reviewed the outbreak in the New England Journal of Medicine, put it: “delays in specimen collection, transportation and testing can postpone confirmation by days or weeks” — time in which the virus can spread.

Why it matters

The resurgence is a case study in a broader lesson: preparedness cannot focus only on the most famous pathogens. Neglected filovirus species can flare up unpredictably, and the tools to fight them — rapid diagnostics, species-specific vaccines and treatments, and lab capacity in affected regions — lag behind. Strengthening those defenses is how outbreaks like this are contained before they grow. This summarizes public-health reporting and is not medical advice.